In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Andrew Coats
Speaker
Andrew Coats
Andrew Coats Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

Specialities : Chronic Heart Failure , General Cardiology

Andrew J. Stewart Coats' main interest is Heart Failure. From Feb 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as CEO of the Norwich Research and Innovation Park, Deputy Vice-Chancellor and Dean of Medicine of the University of Sydney, Head of Cardiology of Imperial College, London and Associate Medical Director and Director of Cardiology of the Royal Brompton and Harefield Hospitals, London. Andrew studied Medicine at Oxford and Cambridge. He has published over 20 patents and more than 650 full research papers and more than 100,000 career citations, with a personal H-index of 135. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve at its president 2020-2022.

74 presentations from this speaker

Are we doing enough for patients with heart failure with reduced ejection fraction?

Event : ESC Congress 2020

  • Session : Making essential treatment choices for heart failure patients: Experts on the spot
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by Novartis Pharma AG

Current and future perspective on heart failure treatment

Event : Webinar 2020

  • Session : HFA Webinars 2020
  • Speaker : J Cleland (Glasgow,GB), JR Teerlink (San Francisco,US), A Coats (Warwickshire,GB)

Device therapies in Heart failure continuum of care: time to treat!

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : J Bax (Leiden,NL), M Senni (Bergamo,IT), A Chow (London,GB), R Von Bardeleben (Mainz,DE), JJ Brugts (Rotterdam,NL), A Coats (Warwickshire,GB)
  • Sponsored by Abbott

Interactive panel discussion.

Event : ESC Congress 2020

  • Session : The changing landscape of iron deficiency in heart failure
  • Speaker : S Anker (Berlin,DE), J Butler (Atlanta,US), A Coats (Warwickshire,GB), EA Jankowska (Wroclaw,PL), P Ponikowski (Wroclaw,PL), P Van Der Meer (Groningen,NL), S Zieroth (Winnipeg,CA)
  • Organised by Charité, supported by Vifor Pharma in the form of an educational grant

Introduction.

Event : ESC Congress 2020

  • Session : Mitral and Tricuspid regurgitation in Heart Failure: Time to treat
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by ABBOTT

Introduction.

Event : ESC Congress 2020

  • Session : Improving Heart Failure outcomes: are we entering a new era of Heart Failure treatment?
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by SERVIER

Introduction.

Event : ESC Congress 2020

  • Session : Making essential treatment choices in heart failure
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by Novartis Pharma AG

Making essential treatment choices in heart failure - Sponsored by Novartis Pharma AG.

Event : ESC Congress 2020

  • Session : Making essential treatment choices in heart failure
  • Speaker : A Coats (Warwickshire,GB), M Senni (Bergamo,IT), J Januzzi (Boston,US), CS Lam (Singapore,SG)
  • Sponsored by Novartis Pharma AG

Management of comorbidities in heart failure.

Event : ESC Congress 2020

  • Session : Chronic Heart Failure - Essential Update
  • Speaker : A Coats (Warwickshire,GB)

Optimal Implementation of HF Therapies: guidelines and challenges.

Event : Webinar 2020

  • Session : HFA Webinars 2020
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)

Pulmonary artery pressure monitoring in LVAD patients: The Cardiologist’s Perspective; Take-Home message.

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : JJ Brugts (Rotterdam,NL), J Bax (Leiden,NL), A Coats (Warwickshire,GB)
  • Sponsored by Abbott

Quality of life questionnaires and the 6-minute-walk-test – what do they mean for the clinician?

Event : ESC Congress 2020

  • Session : The changing landscape of iron deficiency in heart failure
  • Speaker : A Coats (Warwickshire,GB), S Zieroth (Winnipeg,CA)
  • Organised by Charité, supported by Vifor Pharma in the form of an educational grant

Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?

Event : HFA Discoveries 2020

  • Session : Treating hyperkalaemia: A step towards achieving optimal RAASi therapy?
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), I Pina (Detroit,US), M Kosiborod (Kansas,US), M Crespo-Leiro (La Coruna,ES)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre Sponsored by an unrestricted educational grant from AstraZeneca

Universal definition of heart failure - Trilateral cooperative meeting of Heart Failure Association, Heart Failure Society of America and Japanese Heart Failure Society.

Event : HFA Discoveries 2020

  • Session : Universal definition of heart failure - Trilateral cooperative meeting of Heart Failure Association, Heart Failure Society of America and Japanese Heart Failure Society
  • Speaker : A Coats (Warwickshire,GB), B Bozkurt (Houston,US), K Yamamoto (Yonago,JP)

Cardiac contractility modulation.

Event : Heart Failure 2019

  • Session : Parade of devices 1: attend and learn
  • Speaker : A Coats (Warwickshire,GB)

Case-based interactive panel discussion – management of hyperkalaemia.

Event : ESC Congress 2019

  • Session : Hyperkalaemia and iron deficiency management in 2019 – Making the case for better outcomes and quality of life
  • Speaker : P Rossignol (Vandoeuvre Les Nancy,FR), S von Haehling (Berlin,DE), A Coats (Warwickshire,GB)
  • Organised by Charité Universitätsmedizin Berlin, supported by an unrestricted educational grant from Vifor Pharma

Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?

Event : Heart Failure 2019

  • Session : The hyperkalaemia challenge in heart failure: what is the role of novel agents?
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by AstraZeneca

Clinical experience with novel K+ binders: what are the opportunities and challenges?

Event : Heart Failure 2019

  • Session : The hyperkalaemia challenge in heart failure: what is the role of novel agents?
  • Speaker : A Coats (Warwickshire,GB), C Linde (Stockholm,SE), M Volterrani (Rome,IT)
  • Sponsored by AstraZeneca

Concluding comments

Event : ESC Congress 2019

  • Session : Hyperkalaemia and iron deficiency management in 2019 – Making the case for better outcomes and quality of life
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Charité Universitätsmedizin Berlin, supported by an unrestricted educational grant from Vifor Pharma

Conclusion - Optimizing the heart failure patients’ pathway right from the discharge.

Event : Heart Failure 2019

  • Session : Optimizing the heart failure patients’ pathway right from the discharge
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by SERVIER

Conclusion and take-home message.

Event : Heart Failure 2019

  • Session : The Grand Debate 1: Advances in medical and interventional treatment of heart failure
  • Speaker : A Coats (Warwickshire,GB)

Constitution Review.

Event : Heart Failure 2019

  • Session : HFA General Assembly
  • Speaker : A Coats (Warwickshire,GB)

Devices.

Event : Heart Failure 2019

  • Session : The year's best papers on heart failure
  • Speaker : A Coats (Warwickshire,GB)

ESC Congress 2019 together with the World Congress of Cardiology - Focus on heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : A Coats (Warwickshire,GB), T McDonagh (London,GB), M Metra (Brescia,IT)

HFpEF from mechanisms to diagnosis.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : A Coats (Warwickshire,GB), R De Boer (Groningen,NL), B Pieske (Berlin,DE)

Hyperkalaemia: a barrier to optimal management of patients with heart failure?

Event : Heart Failure 2019

  • Session : The hyperkalaemia challenge in heart failure: what is the role of novel agents?
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by AstraZeneca

Introduction

Event : ESC Congress 2019

  • Session : The heart failure patient's journey: key learning and objectives
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by Servier

Management of comorbodities in heart failure.

Event : ESC Congress 2019

  • Session : Chronic heart failure: Essential Update
  • Speaker : A Coats (Warwickshire,GB)

Panel discussion - Innovative devices to better treat heart failure patients.

Event : Heart Failure 2019

  • Session : Innovative devices to better treat heart failure patients
  • Speaker : S Anker (Berlin,DE), A Coats (Warwickshire,GB), P Ponikowski (Wroclaw,PL), H Sievert (Frankfurt,DE), MJ Swaans (Hedel,NL), K Witte (Leeds,GB)
  • Organised by Charité Berlin, supported with educational grants provided by Bioventrix, Cardiac Dimensions and Respicardia

Panel discussion about clinical cases - Optimizing the heart failure patients’ pathway right from the discharge.

Event : Heart Failure 2019

  • Session : Optimizing the heart failure patients’ pathway right from the discharge
  • Speaker : P Liu (Ottawa,CA), A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)
  • Sponsored by SERVIER

Positioning of the topic.

Event : Heart Failure 2019

  • Session : The Grand Debate 1: Advances in medical and interventional treatment of heart failure
  • Speaker : A Coats (Warwickshire,GB)

Prevalence, types and pathophysiology.

Event : Heart Failure 2019

  • Session : Identifying and treating sleep apnea in heart failure
  • Speaker : A Coats (Warwickshire,GB)

The effects of phrenic nerve stimulation on heart rate variability: a case study

Event : Heart Failure 2019

  • Session : Clinical Case
  • Speaker : A Coats (Warwickshire,GB)

The heart failure patient's journey - Questions and answers

Event : ESC Congress 2019

  • Session : The heart failure patient's journey: key learning and objectives
  • Speaker : A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)
  • Sponsored by Servier

The HFA Philip Poole Wilson lecture Introduction of M. Jessup.

Event : Heart Failure 2019

  • Session : Inaugural Session
  • Speaker : A Coats (Warwickshire,GB)

The need to optimize treatments throughout the heart failure patients’ pathway.

Event : Heart Failure 2019

  • Session : Optimizing the heart failure patients’ pathway right from the discharge
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by SERVIER

The role of the baroreflex in heart failure with a reduced ejection fraction

Event : ESC Congress 2019

  • Session : Could neuromodulation via the baroreflex work in heart failure after all?
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by CVRx Inc

Up-to-date management of diabetic patients with heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : A Coats (Warwickshire,GB), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

A patient with beta-blockers in atrial fibrillation - Wrap-up and take home message

Event : Heart Failure 2018

  • Session : Guidelines in daily practice IV - Chronic heart failure
  • Speaker : A Coats (Warwickshire,GB)

Chair’s introduction: let’s meet Dr Gunther.

Event : ESC Congress 2018

  • Session : Why are we not achieving guideline-recommended RAASi doses in heart failure? Dr Gunther’s dilemma
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by AstraZeneca

Chronic heart failure

Event : Heart Failure 2018

  • Session : Drugs in heart failure - Out with the old, in with the new
  • Speaker : A Coats (Warwickshire,GB)

Heart failure and cardiomyopathies.

Event : ESC Congress 2018

  • Session : ESC Congress Highlights
  • Speaker : A Coats (Warwickshire,GB)

Management of comorbidities in heart failure

Event : ESC Congress 2018

  • Session : Heart failure: review, update, and State of the Art in 2018 - Part 1 (Diagnosis and drug treatment)
  • Speaker : A Coats (Warwickshire,GB)

Panel discussion - Baroreflex activation therapy for resistant hypertension and heart failure: the new piece in the puzzle.

Event : ESC Congress 2018

  • Session : Baroreflex activation therapy for resistant hypertension and heart failure: the new piece in the puzzle
  • Speaker : S Anker (Berlin,DE), M Metra (Brescia,IT), G Filippatos (Athens,GR), A Coats (Warwickshire,GB), J Bauersachs (Hannover,DE), A Pathak (Toulouse,FR)
  • Organised by Charité supported with an educational grant from CVRx

Sleep disordered breathing

Event : Heart Failure 2018

  • Session : How to manage my patient with
  • Speaker : A Coats (Warwickshire,GB)

The impact of atrial fibrillation in HFREF and HFPEF

Event : EHRA 2018

  • Session : New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome
  • Speaker : A Coats (Warwickshire,GB)
  • Joint session with the Heart Failure Association of the ESC (HFA)

Treasurer’s Report.

Event : Heart Failure 2018

  • Session : HFA General Assembly
  • Speaker : A Coats (Warwickshire,GB)

Understanding the puzzle: baroreflex – Direct targeting of relevant pathophysiologic mechanisms.

Event : ESC Congress 2018

  • Session : Baroreflex activation therapy for resistant hypertension and heart failure: the new piece in the puzzle
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Charité supported with an educational grant from CVRx

What do we know?

Event : ESC Congress 2018

  • Session : New opportunities for treating heart failure through fixed dose combinations
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by SERVIER

Discussion.

Event : Heart Failure 2017

  • Session : Managing heart failure patients in day-to-day practice
  • Speaker : A Coats (Warwickshire,GB), C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

Importance of the comorbidities in the management of heart failure patients.

Event : Heart Failure 2017

  • Session : Managing heart failure patients in day-to-day practice
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by SERVIER

Mitochondrial function as a therapeutic target in heart failure.

Event : Heart Failure 2017

  • Session : A mitochondrial approach to heart failure
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by Charité Universitätsmedizin Berlin

Reflex control and stimulation in heart failure: do we just need better batteries?

Event : Heart Failure 2017

  • Session : Heart and brain interactions in heart failure: mechanisms and therapies
  • Speaker : A Coats (Warwickshire,GB)

Treasurer's Report.

Event : Heart Failure 2017

  • Session : HFA General Assembly
  • Speaker : A Coats (Warwickshire,GB)

An attempt to explain the reasons for the increase in mortality in SERVE-HF

Event : ESC Congress 2016

  • Session : Treating sleep apnoea in heart failure after SERVE-HF
  • Speaker : A Coats (Warwickshire,GB)

Cardiac contractility modulation (CCM) for heart failure: the trials so far and results of the meta-analysis.

Event : Heart Failure 2016

  • Session : Present and future of device therapy in heart failure
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Charité Medical School Berlin, supported by an unrestricted educational grant from Impulse Dynamics

Discussion - Applying the new ESC Guidelines on heart failure in day to day practice.

Event : ESC Congress 2016

  • Session : Applying the new ESC Guidelines on heart failure in day to day practice
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Universitätsklinikum Des Saarlandes / Course Director: Prof Michael Böhm / Supported by an unrestricted educational grant from SERVIER

Guidelines implementation in patients with co-morbidities.

Event : Heart Failure 2016

  • Session : How to implement the new ESC guidelines on heart failure in clinical practice
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Charité Medical School Berlin

How should we treat our patients today?

Event : Heart Failure 2016

  • Session : Sleep breathing disorders in heart failure
  • Speaker : A Coats (Warwickshire,GB)

Importance of comorbidities

Event : ESC Congress 2016

  • Session : The new ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  • Speaker : A Coats (Warwickshire,GB)

Is there a place for novel devices in the heart failure guidelines?

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on arrhythmias and devices
  • Speaker : A Coats (Warwickshire,GB)

Review of the latest ESC recommandations on heart failure.

Event : ESC Congress 2016

  • Session : Applying the new ESC Guidelines on heart failure in day to day practice
  • Speaker : A Coats (Warwickshire,GB)
  • Organised by Universitätsklinikum Des Saarlandes / Course Director: Prof Michael Böhm / Supported by an unrestricted educational grant from SERVIER

Sleep disturbance, sleep-disordered breathing, depression.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on co-morbidities
  • Speaker : A Coats (Warwickshire,GB)

Device therapy for sleep apnoea.

Event : Heart Failure 2015

  • Session : Novel devices in heart failure
  • Speaker : A Coats (Warwickshire,GB)

How to approach sleep-disordered breathing in heart failure patients? - Take home message.

Event : ESC Congress 2015

  • Session : How to approach sleep-disordered breathing in heart failure patients?
  • Speaker : A Coats (Warwickshire,GB)

How to use beta-blockers in CHF patients with atrial fibrillarion.

Event : Heart Failure 2015

  • Session : New developments and controversial issues in heart failure
  • Speaker : A Coats (Warwickshire,GB)

New devices in the diagnosis and management of heart failure.

Event : ESC Congress 2015

  • Session : Heart failure 2015: update for the clinician
  • Speaker : A Coats (Warwickshire,GB)

Panel discussion.

Event : Heart Failure 2015

  • Session : Treating cardiac health one breath at a time: a new approach for treating central sleep apnea in HF patients
  • Speaker : A Coats (Warwickshire,GB)
  • Sponsored by Charité University Berlin and Respicardia

What is wrong with the skeletal muscle in heart failure.

Event : Heart Failure 2015

  • Session : How to improve skeletal muscle perfomance in heart failure
  • Speaker : A Coats (Warwickshire,GB)

Sleep in heart failure: take home messages.

Event : ESC Congress 2014

  • Session : Sleep in heart failure - a restless problem and therapeutic options
  • Speaker : A Coats (Warwickshire,GB)

Treatment of heart failure with new devices.

Event : ESC Congress 2014

  • Session : What the busy cardiologist needs to know about heart failure - messages from the recent HFA Congress
  • Speaker : A Coats (Warwickshire,GB)

Cardiac contractility modulation: novel devices.

Event : ESC Congress 2013

  • Session : Treatment of chronic heart failure: update 2013
  • Speaker : A Coats (Warwickshire,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are